Ceapro Inc. to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) announced that its CEO, Gilles Gagnon, will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. This virtual event will allow management to engage in one-on-one meetings with registered investors. A video webcast of the presentation will be available on-demand starting September 13, 2021, at 7:00 AM ET, and will be archived for 90 days. Ceapro specializes in developing active ingredients from plant resources for healthcare and cosmetic applications.
- None.
- None.
EDMONTON, Alberta, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, President and Chief Executive Officer of Ceapro will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.
In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website.
A video webcast of the presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM ET for those registered for the event and will be accessible on the Events page in the Investors section of the Company’s website (www.ceapro.com). The webcast replay will be archived for 90 days following the event.
About Ceapro Inc.
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.
For more information contact:
Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com
FAQ
What is Ceapro Inc. presenting at the H.C. Wainwright 23rd Annual Global Investment Conference?
When will the video webcast of Ceapro's presentation be available?
How long will Ceapro's webcast presentation be accessible?
Who is the CEO of Ceapro Inc.?
What is the stock symbol for Ceapro Inc.?
What sectors does Ceapro Inc. focus on?
